Skip to main navigation Skip to search Skip to main content

Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)282-284
Number of pages3
JournalBone Marrow Transplantation
Volume59
Issue number2
DOIs
StatePublished - Feb 2024

Cite this